| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |